Novo Nordisk's American rival, Eli Lilly, has also been testing obesity-beating drugs for children as young as six.
Wegovy and similar drugs for weight loss have become a huge business.
The drugs' success has made Novo Nordisk the most valuable company in Europe.
AdvertisementChildhood obesityAn FDA approval on weight loss drugs for children could open up a new market for Novo Nordisk.
In June, US Sen. Bernie Sanders announced that Novo Nordisk CEO Lars Jørgensen would testify before the committee on September 24 at a hearing focusing on the prices that Novo Nordisk charges Americans for their drugs, Ozempic and Wegovy.
Persons:
—, Saxenda, Novo, Claudia Fox, Eli Lilly, Goldman Sachs, Wegovy, Sen, Bernie Sanders, Lars Jørgensen, Sanders
Organizations:
Service, BMI, Business, FDA, Financial Times, Novo Nordisk, Centers for Disease
Locations:
Madrid, Europe